A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...

In these turblent economic times, your business reputation has never been more important and is in your control. Focusing on your greatest asset will not only safeguard your good name in ...